Covered recipient · General Payments record
ARTHUR HAMO BAGHDANIAN
Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology
General Payments · PY2018–2023
$219,541.02
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $64,262.50 | 26 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BioNTech SE | $43,057.50 | 16 |
| Boehringer Ingelheim RCV GmbH & Co KG | $21,205.00 | 10 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2023 201820212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BioNTech SE | $360.00 | 01/20/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907935 | CMS |
| BioNTech SE | $120.00 | 02/02/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907933 | CMS |
| BioNTech SE | $630.00 | 02/02/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907941 | CMS |
| BioNTech SE | $765.00 | 02/16/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907945 | CMS |
| BioNTech SE | $360.00 | 04/05/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907937 | CMS |
| BioNTech SE | $835.00 | 04/05/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907947 | CMS |
| BioNTech SE | $10,495.00 | 05/05/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907953 | CMS |
| BioNTech SE | $490.00 | 05/11/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907939 | CMS |
| BioNTech SE | $660.00 | 06/01/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907943 | CMS |
| BioNTech SE | $2,580.00 | 06/28/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907951 | CMS |
| BioNTech SE | $1,350.00 | 08/18/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059907949 | CMS |
| BioNTech SE | $11,802.50 | 10/06/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059908073 | CMS |
| BioNTech SE | $9,225.00 | 10/19/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059908071 | CMS |
| BioNTech SE | $480.00 | 11/17/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059908065 | CMS |
| BioNTech SE | $2,150.00 | 11/17/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059908069 | CMS |
| BioNTech SE | $755.00 | 11/21/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1059908067 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $2,480.00 | 01/13/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859713 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $2,465.00 | 03/03/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859705 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $650.00 | 04/05/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859691 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $2,875.00 | 05/11/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859721 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $960.00 | 05/18/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859729 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $3,445.00 | 08/18/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859699 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $4,255.00 | 10/06/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859685 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $1,610.00 | 10/19/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859801 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $1,070.00 | 11/17/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859779 | CMS |
| Boehringer Ingelheim RCV GmbH & Co KG | $1,395.00 | 11/21/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1021859677 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.